What’s the impact of the upcoming insulin discontinuations?

The discontinuation of several insulin products will leave many patients struggling to adjust to new medicine strengths and devices.

What pharmacists need to know about new prescribing pilots

On 19 February, NSW Premier Dominic Perrottet announced that a proposed pharmacist prescribing pilot would go ahead.

Neuropathic pain medicines can increase the risk of falls

These oft-used medicines have become the analgesia of choice for many prescribers. But care should be taken before prescribing gabapentinoids to certain patients. Gabapentinoid medicines...

Managing pain and fever associated with childhood vaccination

Routine childhood vaccinations can sometimes be associated with mild adverse effects. Understanding how non-pharmacological strategies and medicines are used to treat pain or fever episodes in this patient cohort is essential.

High interruption rates threaten patient safety

New research has found that pharmacists are interrupted at alarming rates when dispensing medicines. Led by Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, the...

What pharmacists need to know about the medicinal cannabis shake up

The Australian Health Practitioner Regulation Agency (AHPRA) has cracked down on medicinal cannabis, with new guidance to tighten up the rules and put practitioners...